Skip to content
Home/Companies/Biotech/Repron Therapeutics

Repron Therapeutics

Biotech·Italy·Active·3yr hold
Entry
2023
Hold
3yr
Status
Active

Who owns Repron Therapeutics?

Repron Therapeutics is currently owned by Claris Ventures SGR through Claris Biotech I (2020 vintage), since 2023.

Hand-verified · updated 2026-07-26

Claris Ventures SGR
Investor
Claris Ventures SGR
Claris Biotech I · 2020 · Life Sciences VC

Key facts

HQItaly
SectorBiotech
StatusActive

More from Claris Biotech I

Other portfolio companies in the same fund.

Haptena Therapeutics
Haptena Therapeutics
Active
BiotechItaly· 2025
Lever Bio
Active
BiotechItaly· 2025
Page Therapeutics
Page Therapeutics
Active
BiotechItaly· 2024
ALKemist Bio
ALKemist Bio
Active
BiotechItaly· 2023
Heqet Therapeutics
Heqet Therapeutics
Active
BiotechItaly· 2022
IAMA Therapeutics
Active
BiotechItaly· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
GenSight Biologics
GenSight Biologics
Active
Sofinnova PartnersFrance
Healx
Healx
Active
Amadeus Capital PartnersUK
Track Repron Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on Repron Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue